z-logo
open-access-imgOpen Access
Reversal of New-Onset Diabetes through Modulating Inflammation and Stimulating β-Cell Replication in Nonobese Diabetic Mice by a Dipeptidyl Peptidase IV Inhibitor
Author(s) -
Lei Tian,
Jie Gao,
Jianqiang Hao,
Yu Zhang,
Huimin Yi,
Timothy D. O’Brien,
Robert L. Sorenson,
Jianbin Luo,
Zhiguang Guo
Publication year - 2010
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.95.6.9988
Subject(s) - dipeptidyl peptidase 4 , dipeptidyl peptidase , diabetes mellitus , inflammation , medicine , dipeptidyl peptidase 4 inhibitor , replication (statistics) , endocrinology , biology , type 2 diabetes , enzyme , virology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom